Curebase selected to launch a clinical investigation of a digital therapeutic for IPF
Vicore is a clinical-stage pharmaceutical company focused on developing innovative medicines in severe diseases where the Angiotensin II…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Apr 22
Vicore is a clinical-stage pharmaceutical company focused on developing innovative medicines in severe diseases where the Angiotensin II…
22 Apr 22
Latest innovation for company’s VSP solutions is the only complete design and production service available for radiation therapy…
21 Apr 22
Designed to streamline balloon preparation, the BOBBY balloon guide catheter is already approved in Europe and North America
19 Apr 22
Natus offers medical device solutions for screening, diagnosis, and treatment of disorders related to the brain, neural pathways,…
18 Apr 22
Pursuant to CHP’s amended and restated certificate of incorporation, CHP has determined to liquidate and distribute to the…
14 Apr 22
The system is designed to support the body movement for daily activities during treatment, which was not possible…
14 Apr 22
Pear-010 is a PDT candidate intended to provide a neurobehavioral intervention to patients 18 and older with acute…
13 Apr 22
Alucent Biomedical has designed the technology to unblock arteries and maintain patency in the treatment of lower extremity…
11 Apr 22
I-VASC intends to use the funds to conduct post-market clinical research, gain FDA approval for the US market
11 Apr 22
The wireless neuro-stimulator enables patients to gain access to the treatment from anywhere in the world